| Saham Orang Dalam | 478,504,883 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan null transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di TKMR / . Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-24 | HENRIQUES RICHARD C JR | 1,000 | 6.9500 | 1,000 | 6.9500 | 6,950 | 24 | 7.56 | 610 | 8.78 |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di TKMR / . Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 3 | Gline Matthew By Roivant Sciences Ltd. | ABUS | Common Shares | I | 38,847,462 | ||||||||
| 2025-02-19 | 2025-02-14 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 90,100 | 249,824 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 177,000 | 1,658,003 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 54,300 | 140,544 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Sims Karen | ABUS | Common Shares | D | 49,300 | 155,494 | ||||||
| 2025-02-05 | 2025-02-04 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 3.2830 | -11,333 | -37 | 86,244 | ||||
| 2025-02-05 | 2025-02-04 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 3.2830 | -23,790 | -78 | 1,481,003 | ||||
| 2025-02-05 | 2025-02-04 | 4 | Sims Karen | ABUS | Common Shares | D | 3.2830 | -19,348 | -64 | 106,194 | ||||
| 2025-02-05 | 2025-02-04 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 3.2830 | -22,183 | -73 | 159,724 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 3.6895 | -8,846 | -33 | 46,069 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 0.5600 | 54,915 | 31 | 54,915 | ||||
| 2024-02-05 | 2024-02-02 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 2.3125 | -9,593 | -22 | 181,907 | ||||
| 2024-02-05 | 2024-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 112,500 | 191,500 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sims Karen | ABUS | Common Shares | D | 2.3125 | -4,358 | -10 | 125,542 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sims Karen | ABUS | Common Shares | D | 101,000 | 129,900 | ||||||
| 2024-02-05 | 2024-02-01 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 95,100 | 95,100 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.3125 | -10,164 | -24 | 1,504,793 | ||||
| 2024-02-05 | 2024-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 123,800 | 1,514,957 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 2.3125 | -9,982 | -23 | 1,485,121 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 109,500 | 1,495,103 | ||||||
| 2023-07-12 | 3 | Sims Karen | ABUS | Common Shares | D | 28,900 | ||||||||
| 2023-02-03 | 2023-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 82,200 | 1,385,603 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 83,700 | 1,391,157 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Collier William H. | ABUS | Common Shares | D | 216,500 | 216,500 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 79,000 | 79,000 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Howard Elizabeth | ABUS | Common Shares | D | 69,700 | 86,024 | ||||||
| 2022-05-26 | 2022-05-25 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (Right to Buy) | D | 2.25 | 41,000 | 41,000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 2.25 | 41,000 | 41,000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 2.25 | 41,000 | 41,000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Meyers James R | ABUS | Stock Option (Right to Buy) | D | 2.25 | 41,000 | 41,000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | BURGESS DANIEL D | ABUS | Stock Option (Right to Buy) | D | 2.25 | 41,000 | 41,000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Torti Frank | ABUS | Stock Option (Right to Buy) | D | 2.25 | 41,000 | 41,000 | |||||
| 2022-01-20 | 2022-01-20 | 4 | Picchio Gaston | ABUS | Stock Option (Right to Buy) | D | 2.81 | 2.8100 | 256,500 | 721 | 256,500 | |||
| 2022-01-20 | 2022-01-20 | 4 | Sofia Michael J. | ABUS | Stock Option (Right to Buy) | D | 2.81 | 2.8100 | 285,000 | 801 | 285,000 | |||
| 2022-01-20 | 2022-01-20 | 4 | Howard Elizabeth | ABUS | Stock Option (Right to Buy) | D | 2.81 | 2.8100 | 237,500 | 667 | 237,500 | |||
| 2022-01-20 | 2022-01-20 | 4 | HASTINGS DAVID C | ABUS | Stock Option (Right to Buy) | D | 2.81 | 2.8100 | 285,000 | 801 | 285,000 | |||
| 2022-01-20 | 2022-01-20 | 4 | McElhaugh Michael J. | ABUS | Stock Option (Right to Buy) | D | 2.81 | 2.8100 | 325,850 | 916 | 325,850 | |||
| 2022-01-20 | 2022-01-20 | 4 | Collier William H. | ABUS | Stock Option (Right to Buy) | D | 2.81 | 2.8100 | 787,550 | 2,213 | 787,550 | |||
| 2021-12-03 | 2021-12-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 5.0900 | -200,000 | -1,018 | 1,303,403 | ||||
| 2021-11-12 | 2021-11-09 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 3.50 | 44,000 | 44,000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Series A participating convertible preferred shares | D | 7.13 | -1,164,000 | 0 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Common shares, without par value | D | 22,833,922 | 38,847,462 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2.95 | 22,000 | 22,000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Meyers James R | ABUS | Stock Options | D | 2.95 | 22,000 | 22,000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2.95 | 22,000 | 22,000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2.95 | 22,000 | 22,000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Torti Frank | ABUS | Stock Options | D | 2.95 | 22,000 | 22,000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2.95 | 22,000 | 22,000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Picchio Gaston | ABUS | Stock Options | D | 4.33 | 250,000 | 250,000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 4.33 | 250,000 | 250,000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Collier William H. | ABUS | Stock Options | D | 4.33 | 675,000 | 675,000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 4.33 | 200,000 | 200,000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 4.33 | 249,000 | 249,000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 4.33 | 290,000 | 290,000 | |||||
| 2021-02-10 | 2021-02-09 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5.0000 | -20,000 | -100 | 1,307,457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5.0032 | -10,000 | -50 | 1,327,457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5.0000 | -30,000 | -150 | 1,337,457 | ||||
| 2020-09-25 | 2020-09-23 | 4 | Collier William H. | ABUS | Stock Options | D | 3.35 | 70,000 | 70,000 | |||||
| 2020-09-25 | 2020-09-23 | 4 | Picchio Gaston | ABUS | Common Stock | D | 3.35 | 50,000 | 50,000 | |||||
| 2020-07-27 | 2020-07-23 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5.0100 | -20,000 | -100 | 1,367,457 | ||||
| 2020-06-01 | 2020-05-28 | 4 | Collier William H. | ABUS | Stock Options | D | 3.35 | 262,313 | 262,313 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2.16 | 22,000 | 22,000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Meyers James R | ABUS | Stock Options | D | 2.16 | 22,000 | 22,000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2.16 | 22,000 | 22,000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2.16 | 22,000 | 22,000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2.16 | 22,000 | 22,000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Torti Frank | ABUS | Stock Options | D | 2.16 | 22,000 | 22,000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 3.35 | 200,000 | 200,000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 3.35 | 100,000 | 100,000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Collier William H. | ABUS | Stock Options | D | 3.35 | 367,087 | 367,087 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Picchio Gaston | ABUS | Stock Options | D | 3.35 | 150,000 | 150,000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 3.35 | 250,000 | 250,000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 3.35 | 79,500 | 79,500 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Torti Frank | ABUS | Stock Options | D | 1.50 | 22,000 | 22,000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 1.50 | 22,000 | 22,000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 1.50 | 22,000 | 22,000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Meyers James R | ABUS | Stock Options | D | 1.50 | 22,000 | 22,000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 1.50 | 22,000 | 22,000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | POTTER MYRTLE S | ABUS | Stock Options | D | 1.50 | 22,000 | 22,000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Cheng Andrew | ABUS | Stock Options | D | 1.50 | 60,000 | 60,000 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Collier William H. | ABUS | Employee Stock Option (Right to Buy) | D | 2.18 | 1,112,000 | 1,112,000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 4.57 | 137,500 | 137,500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 4.57 | 137,500 | 137,500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 4.57 | 357,500 | 357,500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | McElhaugh Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4.57 | 104,500 | 104,500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4.57 | 145,000 | 145,000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Picchio Gaston | ABUS | Employee Stock Option (Right to Buy) | D | 4.57 | 137,500 | 137,500 | |||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,774,914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,774,914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,774,914 | ||||||||
| 2018-12-13 | 2018-12-11 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 4.44 | 7,500 | 7,500 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 1.35 | -25,000 | 0 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Common Shares | D | 1.3500 | 25,000 | 34 | 341,396 | ||||
| 2018-11-27 | 2018-11-26 | 4 | Torti Frank | ABUS | Director Share Option (right to buy) | D | 4.72 | 44,000 | 44,000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | POTTER MYRTLE S | ABUS | Director Share Option (Right to Buy) | D | 4.71 | 44,000 | 44,000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | Meyers James R | ABUS | Director Share Option (Right to Buy) | D | 4.71 | 44,000 | 44,000 | |||||
| 2018-10-10 | 2018-10-08 | 4 | Picchio Gaston | ABUS | Employee Share Option (Right to Buy) | D | 9.38 | 200,000 | 200,000 | |||||
| 2018-08-15 | 2018-08-13 | 4/A | Sofia Michael J. Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 | ABUS | Common Shares | I | 9.5143 | -4,250 | -40 | 167,162 | ||||
| 2018-08-14 | 2018-08-13 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 9.5143 | -4,250 | -40 | 1,499,153 | ||||
| 2018-07-13 | 2018-07-11 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 10.0000 | -10,000 | -100 | 1,503,403 | ||||
| 2018-07-10 | 2018-07-09 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8.9060 | -10,000 | -89 | 1,513,403 | ||||
| 2018-07-10 | 2018-07-06 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8.4500 | -10,000 | -84 | 1,523,403 | ||||
| 2018-07-06 | 2018-07-05 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8.4000 | -10,000 | -84 | 1,533,403 | ||||
| 2018-07-06 | 2018-07-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8.0000 | -10,000 | -80 | 1,543,403 | ||||
| 2018-06-25 | 2018-06-19 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 6.75 | 22,000 | 22,000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 6.75 | 22,000 | 22,000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | MANCHESTER KEITH S | ABUS | Director Stock Option (Right to Buy) | D | 6.75 | 22,000 | 22,000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | Ramaswamy Vivek | ABUS | Director Stock Option (Right to Buy) | D | 6.75 | 22,000 | 22,000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 6.75 | 22,000 | 22,000 | |||||
| 2018-06-21 | 2018-06-19 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 6.75 | 200,000 | 200,000 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 5.20 | 160,000 | 160,000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 5.20 | 25,000 | 25,000 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 0.35 | -27,007 | 0 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Common Shares | D | 0.3540 | 27,007 | 10 | 316,396 | ||||
| 2018-04-17 | 2018-04-16 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 5.20 | 418,187 | 418,187 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 5.20 | 150,000 | 150,000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 5.20 | 30,000 | 30,000 | |||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5,500 | ||||||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5,500 | ||||||||
| 2018-01-16 | 2018-01-12 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Lo Andrew | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Machado Patrick See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7.13 | 100.0000 | 664,000 | 66,400 | 1,164,000 | |||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2017-10-18 | 2017-10-16 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Lo Andrew See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Machado Patrick | ABUS | Series A Participating Convertible Preferred Shares | I | 7.13 | 100.0000 | 500,000 | 50,000 | 500,000 | |||
| 2017-10-05 | 2017-10-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8.0000 | -10,000 | -80 | 1,553,403 | ||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3.6750 | -20,000 | -74 | 171,412 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3.7500 | -10,000 | -38 | 191,412 | ||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2017-06-23 | 2017-06-21 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3.55 | 22,000 | 22,000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 3.55 | 22,000 | 22,000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | Ramaswamy Vivek | ABUS | Stock Option (Right to Buy) | D | 3.55 | 22,000 | 22,000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option Grant (Right to Buy) | D | 3.55 | 22,000 | 22,000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option Grant (Right to Buy) | D | 3.55 | 22,000 | 22,000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option Grant (Right to Buy) | D | 3.55 | 22,000 | 22,000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3.15 | 125,000 | 125,000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3.15 | 450,000 | 450,000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3.15 | 150,000 | 150,000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 3.15 | 50,000 | 50,000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3.15 | 200,000 | 200,000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3.15 | 125,000 | 125,000 | |||||
| 2017-03-27 | 2017-03-24 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 3.15 | 50,000 | 50,000 | |||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0.35 | 13,503 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0.35 | 675 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Common Shares | D | 0.3455 | 14,178 | 5 | 42,097 | ||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32,027,080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32,027,080 | ||||||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Warrants | D | 2.57 | -5,000 | 0 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Common Shares | D | 2.5688 | 5,000 | 13 | 289,389 | ||||
| 2016-06-07 | 2016-06-03 | 4 | KARBE FRANK | ABUS | Director Stock Option (Right to Buy) | D | 3.99 | 7,500 | 7,500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 3.99 | 7,500 | 7,500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 3.99 | 7,500 | 7,500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3.99 | 7,500 | 7,500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 3.99 | 7,500 | 7,500 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 50,000 | 50,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 145,000 | 145,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Kowalski Mark | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 85,000 | 85,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 60,000 | 60,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 450,000 | 450,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Symonds William T. | ABUS | Executive Stock Option (Right to Buy) | D | 3.94 | 25,000 | 25,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 100,000 | 100,000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3.94 | 120,000 | 120,000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17.57 | 35,000 | 35,000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17.57 | 75,000 | 75,000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17.57 | 100,000 | 100,000 | |||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77,516 | ||||||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77,516 | ||||||||
| 2015-12-22 | 2015-07-09 | 4 | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17.57 | 100,000 | 100,000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17.57 | 75,000 | 75,000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17.57 | 35,000 | 35,000 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Employee Stock Option (right to buy) | D | 0.44 | -219,428 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Common Shares | D | 0.4444 | 219,428 | 98 | 284,389 | ||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Employee Stock Option (right to buy) | D | 0.44 | -17,044 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Common Shares | D | 0.4444 | 17,044 | 8 | 27,919 | ||||
| 2015-08-26 | 2015-08-24 | 4 | HENRIQUES RICHARD C JR | ABUS | Common Shares | D | 6.9500 | 1,000 | 7 | 1,000 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 9.11 | 7,500 | 7,500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 9.11 | 7,500 | 7,500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 9.11 | 7,500 | 7,500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | CONRAD HERBERT J | ABUS | Stock Option (Right to Buy) | D | 9.11 | 7,500 | 7,500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 9.11 | 7,500 | 7,500 | |||||
| 2015-04-08 | 2015-03-30 | 4 | HENRIQUES RICHARD C JR | TKMR | Stock Option (right to buy) | D | 17.57 | 15,000 | 15,000 | |||||
| 2015-04-07 | 2015-03-30 | 4 | CONRAD HERBERT J | TKMR | Stock Option (right to buy) | D | 17.57 | 15,000 | 15,000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Abrams Michael J. | TKMR | Stock Option (right to buy) | D | 17.57 | 50,000 | 50,000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Cousins Bruce | TKMR | Stock Option (right to buy) | D | 17.57 | 80,000 | 80,000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Murray Mark J. | TKMR | Stock Option (right to buy) | D | 17.57 | 180,000 | 180,000 | |||||
| 2015-03-16 | 3 | CONRAD HERBERT J | TKMR | Common Stock | D | 0 | ||||||||
| 2015-03-16 | 3 | MANCHESTER KEITH S | TKMR | Common Stock, no par value | I | 0 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3,328,218 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1,966,227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1,966,227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3,328,218 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32,027,080 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32,027,080 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512,654 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512,654 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3,529,630 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3,529,630 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32,081,995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16,123,370 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32,081,995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16,123,370 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32,027,080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32,027,080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32,027,080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32,027,080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32,027,080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32,027,080 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38,000 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38,000 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21,750 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21,750 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129,922 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129,922 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969,330 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969,330 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77,516 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77,516 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20,000 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20,000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10,000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10,000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25,000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25,000 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
